AVITA Medical RECELL GO Australia approval boosts expansion plans
Synopsis
AVITA Medical wins regulatory approval for its RECELL GO system in Australia and New Zealand, marking a key step in expanding advanced burn care technology, even as the company continues to invest heavily and navigate profitability challenges.
AVITA Medical has secured regulatory clearance for its RECELL GO system in Australia and New Zealand, marking a key milestone in expanding its advanced burn treatment technology, even as the company continues to invest heavily in growth and remains unprofitable.
Key highlights
- RECELL GO approved by Australian and New Zealand regulators
- Commercial launch expected within weeks via distribution partner
- Technology improves burn treatment efficiency and reduces graft need
- Revenue strong but company remains unprofitable amid expansion
- Analysts see potential upside as stock trades below fair value
What Happened
AVITA Medical announced that its RECELL GO system has received certification from Australia’s Therapeutic Goods Administration and has been listed on New Zealand’s Medsafe device database.
The system is designed to automate the preparation of Spray-On Skin for treating burn and trauma wounds. It combines a reusable processing unit with a single-use kit capable of treating wounds up to 1,920 cm².
The company’s regional partner, Revolution Surgical Pty Ltd, is expected to begin commercial rollout in Australia and New Zealand within weeks.
Why This Matters
The approval strengthens AVITA’s presence in key Asia-Pacific markets and expands access to advanced burn care technology that reduces the need for traditional skin grafts.
RECELL technology uses a patient’s own skin cells, helping minimise complications and improve recovery outcomes. The automated RECELL GO system further enhances consistency, reduces training requirements, and improves efficiency for clinicians.
Despite strong gross margins, the company remains unprofitable as it continues investing in scaling operations and expanding market access globally.
Official Statements
Professor Fiona Wood, who originally developed RECELL technology, said the certification is major in improving access to treatment for burn and trauma patients across Australia and New Zealand.
Interim CEO Cary Vance described the approval as a key milestone in expanding the company’s footprint and delivering its technology to more patients globally.
Financial & Market Context
AVITA Medical reported revenue of $71.6 million over the past 12 months, with a strong gross margin of 82%, reflecting solid demand for its technology.
However, the company remains loss-making as it prioritises growth. Its stock has been volatile, declining sharply over the past year despite a rebound in recent months. Analysts note the stock may be undervalued, with improving earnings expectations.
RECELL GO has already received approvals in major markets including the United States, Europe, the United Kingdom and Japan, positioning the company for broader global adoption.
What Happens Next
The focus now shifts to the commercial launch in Australia and New Zealand, which could drive incremental revenue growth in the near term.
Investors will also watch whether AVITA can translate regulatory wins into sustained profitability while expanding its global footprint in advanced wound care.
FAQs
Q1: What is RECELL GO?
RECELL GO is an automated system that prepares Spray-On Skin using a patient’s own cells to treat burns and trauma wounds.
Q2: Why is this approval important?
It allows AVITA Medical to expand access to its technology in Australia and New Zealand, strengthening its global presence.
Q3: Is AVITA Medical profitable?
No, the company is currently unprofitable as it continues investing in growth, despite strong revenue and margins.
Q4: When will RECELL GO launch in these markets?
Commercial rollout is expected within weeks through its regional distribution partner.
Follow Inspirepreneur Magazine for daily global business news.
I write about markets, money, and the macro forces that move them. Passionate about turning complex economic trends into sharp, easy-to-understand stories. Off the clock, it’s hip hop, rock, reggae -- and a mix of cricket and basketball.
You Might Also Like
Controversial Ex-Mayor To Return Amid Whittlesea’s Monitors Reappointment
4D Medical Shares Fall Despite Winning Australian TGA Approval
